|Articles|December 1, 2002

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components
Volume 8
Issue 18 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

over 23 years ago

Article

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components

over 23 years ago

Article

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

over 23 years ago

Article

Quality of Life and Symptom Measures in Oncology: An Overview

over 23 years ago

Article

Quality-of-Life Measurements: A Soft Outcome - Or is it?

over 23 years ago

Article

The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

over 23 years ago

Article

Continuing Medical Education Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Participating Faculty

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

AI Chatbots Score Below 28% on Colorectal Cancer Questions

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Participating Faculty

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

AI Chatbots Score Below 28% on Colorectal Cancer Questions